How long is too long? Understanding Denosumab duration
| Sunday, May 4, 2025 |
| 2:20 PM - 2:40 PM |
Overview
Joy Gailer
Details
Denosumab is a widely used treatment for osteoporosis and other bone-related conditions. This session will explore the duration of Denosumab therapy, including the recommended treatment intervals, its long-term efficacy, and considerations for patient management. Pharmacists will gain insights into how to monitor and adjust treatment plans based on individual patient needs.
Learning objectives:
1. Discuss the recommended duration of Denosumab therapy and its implications for patient care.
Competency standards (2016): 1.6, 3.5
Speaker
Miss Joy Gailer
Senior Pharmacist
Drug And Therapeutics Information Service
How long is too long? Understanding denosumab duration
Biography
Joy is a credentialed Advanced Practice Pharmacist and US Board Certified Pharmacotherapy Specialist pharmacist with the Drug and Therapeutics Information Service (DATIS), and the practice support clinical pharmacist at Chandlers Hill Surgery. She is passionate about assisting patients, pharmacists, doctors and nurses make the best possible decisions relating to medicine use.
